Candida auris : Disinfectants and Implications for Infection Control

Frontiers in Microbiology
Tsun S N KuSamuel A Lee


Candida auris is a rapidly emerging pathogen and is able to cause severe infections with high mortality rates. It is frequently misidentified in most clinical laboratories, thus requiring more specialized identification techniques. Furthermore, several clinical isolates have been found to be multidrug resistant and there is evidence of nosocomial transmission in outbreak fashion. Appropriate infection control measures will play a major role in controlling the management and spread of this pathogen. Unfortunately, there are very few data available on the effectiveness of disinfectants against C. auris. Chlorine-based products appear to be the most effective for environmental surface disinfection. Other disinfectants, although less effective than chlorine-based products, may have a role as adjunctive disinfectants. A cleaning protocol will also need to be established as the use of disinfectants alone may not be sufficient for maximal decontamination of patient care areas. Furthermore, there are fewer data on the effectiveness of antiseptics against C. auris for patient decolonization and hand hygiene for healthcare personnel. Chlorhexidine gluconate has shown some efficacy in in vitro studies but there are reports of patients wit...Continue Reading


Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M B EdmondR P Wenzel
Oct 26, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J SilvermanM J Zervos
Jan 11, 2000·Clinical Microbiology Reviews·M A Ghannoum
Sep 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R M Donlan
Dec 3, 2002·Nature Reviews. Genetics·Judith Berman, Peter E Sudbery
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Oct 19, 2006·The Journal of Hospital Infection·D Lindsay, A von Holy
Jun 25, 2008·Antimicrobial Agents and Chemotherapy·Jeniel E NettDavid R Andes
Jul 17, 2008·Journal of Medical Microbiology·Karen Smith, Iain S Hunter
Jan 12, 2010·The Journal of Hospital Infection·T WatamotoC J Seneviratne
Jun 10, 2010·Annual Review of Microbiology·Kim Lewis
Aug 28, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Matthew E FalagasKonstantinos Z Vardakas
Jan 11, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuHenry F Chambers
Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Apr 13, 2012·PLoS Pathogens·Saranna Fanning, Aaron P Mitchell
Oct 23, 2012·International Journal of Antimicrobial Agents·N SalimR Rautemaa
Mar 8, 2013·American Journal of Infection Control·Curtis J Donskey
Jun 8, 2013·Current Opinion in Infectious Diseases·David J WeberWilliam A Rutala
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Oct 12, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ing-Moi HiiChih-Yen Chang
Dec 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ChowdharyJ F Meis
Jan 15, 2014·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Ghada N Al-Rawahi, Diane L Roscoe
Jun 24, 2014·Scandinavian Journal of Infectious Diseases·Mustafa YildirimCigdem Ozaydin
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
May 20, 2015·Emerging Infectious Diseases·Maha EmaraRitu Bafna
Sep 10, 2015·Microbiology Spectrum·Jyotsna Chandra, Pranab K Mukherjee
Jan 29, 2016·Clinical Microbiology Reviews·Edward J Septimus, Marin L Schweizer
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Sep 20, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·David R AndesUNKNOWN TRANSNET Investigators
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher
Dec 17, 2016·Emerging Infectious Diseases·Sara StrolloD Rebecca Prevots
Dec 17, 2016·Emerging Infectious Diseases·Soraya E Morales-LópezJosé Y Rodríguez
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva
Jan 19, 2017·Emerging Infectious Diseases·Ronen Ben-AmiTalya Finn
Jan 19, 2017·Emerging Infectious Diseases·Leighann SherryRiina Rautemaa-Richardson

❮ Previous
Next ❯


Aug 18, 2018·Journal of Fungi·Ronen Ben-Ami
Oct 20, 2018·Emerging Infectious Diseases·Nelesh P GovenderJuno Thomas
Dec 6, 2018·Acta Clinica Belgica·Klaas DewaeleKatrien Lagrou
May 23, 2019·Journal of Occupational and Environmental Hygiene·Steven R TorresMagdia De Jesus
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Jul 3, 2019·Current Pharmaceutical Design·Brenna L C GondimAna C D Medeiros
Sep 21, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Vijeta BajpaiPurva Mathur
Jan 31, 2020·Journal of Clinical Microbiology·Brian L Wickes
Mar 1, 2020·Journal of Fungi·Ryan KeanGordon Ramage
Apr 3, 2020·Expert Review of Anti-infective Therapy·Arunaloke Chakrabarti, Shreya Singh
May 3, 2019·Critical Care : the Official Journal of the Critical Care Forum·Andrea CortegianiDavid Eyre
Sep 30, 2020·Intensive Care Medicine·C LoganT Bicanic
Nov 7, 2018·Journal of Intensive Care·Andrea CortegianiAnuradha Chowdhary
Sep 8, 2018·Intensive Care Medicine·Andrea CortegianiAnuradha Chowdhary
Dec 19, 2019·Frontiers in Microbiology·Farid ChaabaneAlix T Coste
Dec 24, 2018·Materials·Katarzyna Ledwoch, Jean-Yves Maillard
Aug 24, 2019·Emerging Infectious Diseases·Erika van SchalkwykUNKNOWN GERMS-SA
Sep 7, 2019·JAMA : the Journal of the American Medical Association·Suzanne F Bradley
Aug 20, 2019·Internal Medicine Journal·Chong W OngUNKNOWN Australian and New Zealand Mycoses Interest Group (ANZMIG); and the Healthcare Infection Control Special Interest Group (HIC
Nov 26, 2020·Journal of Fungi·Wadha AlfouzanMohammad R Al-Rashidi
Dec 4, 2020·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Vicente MirabetJavier Pemán
Dec 17, 2020·Frontiers in Cellular and Infection Microbiology·Gina WallJose L Lopez-Ribot
Feb 3, 2021·Journal of the Pediatric Infectious Diseases Society·Jorge L Alvarado-SocarrasAlfonso J Rodriguez-Morales
Apr 1, 2021·Indian Journal of Medical Microbiology·Ahmet Furkan KurtGokhan Aygun
May 20, 2021·Mycoses·João Nobrega de AlmeidaUNKNOWN Candida auris Brazilian Study Group
May 18, 2021·Enfermedades Infecciosas Y Microbiologia Clinica·Juan Vicente Mulet-BayonaConcepción Gimeno-Cardona
Jan 17, 2020·ACS Applied Materials & Interfaces·Humberto H LaraJose Lopez-Ribot

❮ Previous
Next ❯

Methods Mentioned

blood draws

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Hospital Infection
Markus Dettenkofer, R C Spencer
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Matthias Maiwald
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Marwan M AzarVirginia M Pierce
© 2021 Meta ULC. All rights reserved